Indian shares rose more than 2% to a near seven-week high on Thursday, as global sentiment improved on promising early results from a COVID-19 treatment trial and on gains in heavyweight Reliance Industries ahead of its results.
Nifty, Sensex jump 2% on COVID-19 drug hopes